News | Radiation Therapy | August 03, 2016

National Cancer Institute Leader Talks Cancer Moonshot at AAPM

Spoke to medical physicists, who play key role in cancer diagnosis, treatment

NCI, Cancer Moonshot, radiation therapy

Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI).

Providing insights into the Cancer Moonshot and other initiatives to accelerate cancer research and make more therapies available to patients, Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI), led a plenary session at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

Medical physicists play a vital role in the diagnosis and treatment of cancer, through the development of novel imaging techniques, advancement of innovative therapy approaches, and ensuring the clinical use of imaging and radiation therapy are safe and effective. The NCI currently is funding several research initiatives on imaging and radiation therapy to better understand how to use immunotherapies in combination with targeted therapies and treatments such as chemotherapy and radiation.

“As medical physicists, we look forward to exploring ways in which our unique skills in the safe and accurate use of technology and radiation can advance the goals of the Cancer Moonshot,” said Bruce H. Curran, M.Eng., M.S., president of AAPM and associate professor of radiation oncology at VCU Health Systems, Richmond, Va. “We play a vital role as professionals involved not only in helping to treat cancer patients, but improving diagnosis and monitoring the response of cancer therapies during treatment.”

A longtime researcher, Lowy is one of the most highly cited authors in microbiology, and a member of the National Academy of Sciences and the Institute of Medicine. He received the 2007 Federal Employee of the Year Award from the Partnership for Public Service, the 2007 Dorothy P. Landon-American Association for Cancer Research Prize for Translational Cancer Research, the Sabin Gold Medal in 2011 and the National Medal of Technology and Innovation from President Obama in 2014, among others.

Lowy’s research focuses on papillomaviruses and the regulation of normal and neoplastic growth. In the 1980s he identified the oncogenes encoded by papillomaviruses and recently worked on papillomavirus vaccines and its life cycle.

For more information: www.aapm.org/meetings/2016AM

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation